Image

Middle East and Africa Ocular Pain Market – Industry Trends and Forecast to 2028

Healthcare

Image

Middle East and Africa Ocular Pain Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Oct 2021
  • MEA
  • 350 Pages
  • No of Tables: 214
  • No of Figures: 56

Middle East and Africa Ocular Pain Market, By Disease Type (Ocular Pain with Eye Diseases and Ocular Pain without Primary Eye Diseases), Type (Diagnosis and Treatment), Application (Conjunctivitis, Corneal Abrasion, Blepharitis, Sty, Iritis, Sinusitis, Migraines, Glaucoma, and Others), Route of Administration (Topical, Periocular, Intraocular, Oral and Others), Drug Type (Prescription and Over the Counter), Population Type  (Adults and Geriatric), End User (Hospitals, Specialty Clinics, Home Healthcare Settings, Ophthalmology Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, Kuwait and Rest of the Middle East and Africa) – Industry Trends and Forecast to 2028.

Middle East and Africa Ocular Pain Market Market Analysis and Insights: Middle East and Africa Ocular Pain Market

Middle East and Africa ocular pain market is expected to grow in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 2.9% in the forecast period of 2021 to 2028 and is expected to reach USD 29.65 million by 2028. Increasing unhygienic and sedentary lifestyles drive the Middle East and Africa ocular pain market growth.

Ocular pain also, known as eye pain, commonly occurs due to mild irritation, but it is rarely a symptom of a serious condition. Mostly the pain resolves without medicine or further treatment, and it recovers by the self-immune system. However, ocular pain with underlying primary ophthalmic disorders requires timely treatment. Eye pains are generally categorized under two categories, such as ocular pain, which occurs over the eye's surface, creating sensations of scratching, burning, or itching. They are caused due to a person’s eyelashes, foreign objects, infection, or trauma. Often ocular pain is treated with eye drops and topical steroids or NSAIDs. Ocular pain occurs with underlying primary eye diseases like conjunctivitis, contact lens irritation, corneal abrasion, injury, blepharitis, and sty. The other advanced treatments, like stimulation therapies, are also used for severe neuro ocular pain, appropriately diagnosed.

Increasing unhygienic and sedentary lifestyle, rising prevalence of ophthalmic disorders, and ocular pain act as drivers for the Middle East and Africa ocular pain market. The increasing awareness among people for eye-related diseases and growing cases of ocular migraine is further boosting the market growth. The side effects of eye treatment medicines and the high cost of eye treatment and medication are restraining the Middle East and Africa ocular pain market growth. Increasing research and development activities, rising healthcare expenditure and disposable income, and growing geriatric population act as opportunities for the Middle East and Africa ocular pain market. Lack of healthcare facilities for eye treatment and stringent regulatory framework poses a challenge for the growth of the Middle East and Africa ocular pain market.

The ocular pain market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the ocular pain market scenario, contact Data Bridge Market Research for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Ocular Pain Market Middle East and Africa Ocular Pain Market Scope and Market Size

Middle East and Africa ocular pain market is segmented based on disease type, type, application, route of administration, drug type, population type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of disease type, the Middle East and Africa ocular pain market is segmented into ocular pain with eye diseases and ocular pain without primary eye diseases. In 2021, the ocular pain with eye diseases segment is expected to dominate the Middle East and Africa ocular pain market due to the region's rising prevalence of severity of ocular pain disorders.
  • On the basis of type, the Middle East and Africa ocular pain market is segmented into diagnosis and treatment. In 2021, the diagnosis segment is expected to dominate dominating the market due to increasing funds for technological advancement.
  • On the basis of application, the Middle East and Africa ocular pain market is segmented into conjunctivitis, corneal abrasion, blepharitis, sty, iritis, sinusitis, migraines, glaucoma, and others. In 2021, the glaucoma segment is expected to dominate the market as major ophthalmic disorders accompany glaucoma.
  • On the basis of route of administration, the Middle East and Africa ocular pain market is segmented into topical, periocular, intraocular, oral, and others. In 2021, the topical segment is expected to dominate the market due to their easy, convenient application.
  • On the basis of drug type, the Middle East and Africa ocular pain market is segmented into prescription and over the counter. In 2021, the prescription segment is expected to dominate the market as people prefer it to prevented unwanted side effects.
  • On the basis of population type, the Middle East and Africa ocular pain market is segmented into adults and geriatric. In 2021, the adults segment is expected to dominate the market due to the increasing adult population and their careless nature over eye healthcare.
  • On the basis of end user, the Middle East and Africa ocular pain market is segmented into hospitals, specialty clinics, home healthcare, ophthalmology centers, ambulatory surgical centers, and others. In 2021, the hospitals segment is expected to dominate the market due to increased funds by the government and market players.
  • On the basis of distribution channel, the Middle East and Africa ocular pain market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy, and others. In 2021, the direct tender segment is expected to dominate the market because they provide quality products for the far reach.

Middle East and Africa Ocular Pain Market Country Level Analysis

Middle East and Africa ocular pain market is analyzed, and market size information is provided by the country, disease type, type, application, route of administration, drug type, population type, end user, and distribution channel as referenced above.

The countries covered in the Middle East and Africa ocular pain market report are South Africa, Saudi Arabia, U.A.E., Israel, Egypt, and the rest of the Middle East and Africa.

The adults segment in South Africa of the Middle East and Africa region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing cases of ophthalmic disorders among adults. The adults segment in Saudi Arabia is the second dominating market in the European region due to the increasingly sedentary lifestyle of the adult population. The UAE is the third leading country, and the adults segment dominates in this country due to the highest number of vulnerable people.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the Middle East and African brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to Enhance the Awareness for Ocular Pain Treatment is Boosting the Market Growth of Middle East and Africa Ocular Pain Market

Middle East and Africa ocular pain market also provide you with a detailed market analysis for every country's growth in a particular market. Additionally, it provides detailed information regarding the market players’ strategy and their geographical presence. The data is available for the historical period 2010 to 2019.

Competitive Landscape and the Middle East and Africa Ocular Pain Market Share Analysis

Middle East and Africa ocular pain market competitive landscape provide details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the Middle East and Africa ocular pain market.

The major companies dealing in the Middle East and Africa ocular pain market are Johnson & Johnson Services, Inc., Pfizer Inc., Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Novartis AG, Allergan (An AbbVie Company), Tarsier Pharma Ltd, and among others are domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contracts and agreements are also initiated by companies worldwide, which accelerate the Middle East and Africa ocular pain market.

For instance,

  • In August 2021, Tarsier Pharma Ltd participated in the H.C. Wainwright Ophthalmology Virtual Conference. The CEO of the company demonstrated their products current clinical-stage progress to attended customers, gaining more attention of market leaders
  • In May 2020, Allergan Plc was acquired by AbbVie Inc. This acquisition made AbbVie take over all the four therapeutic areas, medical aesthetics, eye care, central nervous system, and gastroenterology of Allergan. This improved the presence of their products over the market

Collaboration, product launch, business expansion, award and recognition, joint ventures, and other strategies by the market player enhance the company's footprints in the ocular pain market, which also benefits the organization’s profit growth.


SKU-

TABLE 1 AVERAGE PRICING ANALYSIS OF VARIOUS TREATMENT PRODUCTS

TABLE 2 VOLUME OF PRESCRIPTION (%)

TABLE 3 MIDDLE EAST & AFRICA OCULAR PAIN MARKET, PIPELINE ANALYSIS

TABLE 4 MIDDLE EAST & AFRICA OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA DIAGNOSIS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA TREATMENT IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA GLAUCOMA IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA BLEPHARITIS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA CONJUNCTIVITIS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA CORNEAL ABRASION IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA STY IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA IRITIS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA SINUSITIS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA MIGRAINES IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA OTHERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA TOPICAL IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA INTRAOCULAR IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA PERIOCULAR IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA ORAL IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA OTHERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA PRESCRIPTION IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA OVER THE COUNTER IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA ADULTS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA GERIATRIC IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA HOSPITALS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA SPECIALTY CLINICS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA HOME HEALTHCARE IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA OPHTHALMOLOGY CENTERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA OTHERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 53 MIDDLE EAST & AFRICA OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 54 MIDDLE EAST & AFRICA DIRECT TENDER IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 55 MIDDLE EAST & AFRICA HOSPITAL PHARMACY IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 56 MIDDLE EAST & AFRICA RETAIL PHARMACY IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 57 MIDDLE EAST & AFRICA ONLINE PHARMACY IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 58 MIDDLE EAST & AFRICA OTHERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 59 MIDDLE EAST AND AFRICA OCULAR PAIN MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 60 MIDDLE EAST AND AFRICA OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 61 MIDDLE EAST AND AFRICA OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 62 MIDDLE EAST AND AFRICA OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 63 MIDDLE EAST AND AFRICA OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 64 MIDDLE EAST AND AFRICA DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 65 MIDDLE EAST AND AFRICA SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 MIDDLE EAST AND AFRICA IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 67 MIDDLE EAST AND AFRICA TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 MIDDLE EAST AND AFRICA LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 MIDDLE EAST AND AFRICA TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 70 MIDDLE EAST AND AFRICA NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 71 MIDDLE EAST AND AFRICA STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 72 MIDDLE EAST AND AFRICA OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 MIDDLE EAST AND AFRICA OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 74 MIDDLE EAST AND AFRICA TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 75 MIDDLE EAST AND AFRICA INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 76 MIDDLE EAST AND AFRICA PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 77 MIDDLE EAST AND AFRICA ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 78 MIDDLE EAST AND AFRICA OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 79 MIDDLE EAST AND AFRICA OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 80 MIDDLE EAST AND AFRICA OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 81 MIDDLE EAST AND AFRICA OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 82 SOUTH AFRICA OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 83 SOUTH AFRICA OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 84 SOUTH AFRICA OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 85 SOUTH AFRICA OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 86 SOUTH AFRICA DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 87 SOUTH AFRICA SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 88 SOUTH AFRICA IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 SOUTH AFRICA TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 90 SOUTH AFRICA LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 91 SOUTH AFRICA TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 92 SOUTH AFRICA NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 93 SOUTH AFRICA STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 94 SOUTH AFRICA OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 95 SOUTH AFRICA OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 96 SOUTH AFRICA TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 97 SOUTH AFRICA INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 98 SOUTH AFRICA PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 99 SOUTH AFRICA ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 100 SOUTH AFRICA OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 101 SOUTH AFRICA OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 102 SOUTH AFRICA OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 103 SOUTH AFRICA OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 104 SAUDI ARABIA OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 105 SAUDI ARABIA OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 106 SAUDI ARABIA OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 107 SAUDI ARABIA OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 108 SAUDI ARABIA DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 109 SAUDI ARABIA SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 110 SAUDI ARABIA IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 111 SAUDI ARABIA TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 112 SAUDI ARABIA LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 113 SAUDI ARABIA TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 114 SAUDI ARABIA NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 115 SAUDI ARABIA STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 116 SAUDI ARABIA OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 117 SAUDI ARABIA OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 118 SAUDI ARABIA TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 119 SAUDI ARABIA INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 120 SAUDI ARABIA PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 121 SAUDI ARABIA ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 122 SAUDI ARABIA OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 123 SAUDI ARABIA OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 124 SAUDI ARABIA OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 125 SAUDI ARABIA OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 126 UAE OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 127 UAE OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 128 UAE OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 129 UAE OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 130 UAE DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 131 UAE SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 132 UAE IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 133 UAE TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 134 UAE LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 135 UAE TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 136 UAE NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 137 UAE STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 UAE OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 139 UAE OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 140 UAE TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 141 UAE INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 142 UAE PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 143 UAE ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 144 UAE OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 145 UAE OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 146 UAE OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 147 UAE OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 148 EGYPT OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 149 EGYPT OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 150 EGYPT OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 151 EGYPT OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 152 EGYPT DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 153 EGYPT SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 154 EGYPT IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 155 EGYPT TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 156 EGYPT LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 157 EGYPT TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 158 EGYPT NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 159 EGYPT STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 160 EGYPT OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 161 EGYPT OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 162 EGYPT TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 163 EGYPT INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 164 EGYPT PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 165 EGYPT ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 166 EGYPT OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 167 EGYPT OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 168 EGYPT OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 169 EGYPT OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 170 KUWAIT OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 171 KUWAIT OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 172 KUWAIT OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 173 KUWAIT OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 174 KUWAIT DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 175 KUWAIT SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 176 KUWAIT IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 177 KUWAIT TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 178 KUWAIT LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 179 KUWAIT TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 180 KUWAIT NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 181 KUWAIT STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 182 KUWAIT OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 183 KUWAIT OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 184 KUWAIT TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 185 KUWAIT INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 186 KUWAIT PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 187 KUWAIT ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 188 KUWAIT OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 189 KUWAIT OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 190 KUWAIT OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 191 KUWAIT OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 192 ISRAEL OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 193 ISRAEL OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 194 ISRAEL OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 195 ISRAEL OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 196 ISRAEL DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 197 ISRAEL SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 198 ISRAEL IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 199 ISRAEL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 200 ISRAEL LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 201 ISRAEL TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 202 ISRAEL NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 203 ISRAEL STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 204 ISRAEL OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 205 ISRAEL OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 206 ISRAEL TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 207 ISRAEL INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 208 ISRAEL PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 209 ISRAEL ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 210 ISRAEL OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 211 ISRAEL OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 212 ISRAEL OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 213 ISRAEL OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 214 REST OF MIDDLE EAST AND AFRICA OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials